Dabur India-Sesa Care amalgamation cleared by NCLT 2026

What the NCLT order changes for Dabur

The National Company Law Tribunal (NCLT), New Delhi Bench, has sanctioned the Scheme of Amalgamation of Sesa Care Private Limited with Dabur India Limited. The order was pronounced on September 24, 2026, giving Dabur a key regulatory clearance to fold the premium Ayurvedic hair care brand into its listed FMCG business. The scheme is being executed under Sections 230 to 232 of the Companies Act, 2013.

While the approval is a major milestone, the merger becomes effective only after completion of statutory filings and satisfaction of other conditions specified under the scheme. Dabur has indicated it will notify stock exchanges and update its website upon receipt of the final copy of the NCLT order.

The deal in brief: Sesa Care moves into Dabur

Sesa Care will be merged into Dabur India, consolidating the Ayurvedic hair care franchise inside Dabur’s existing hair care portfolio. The transaction was first announced in October 2024, when Dabur disclosed an agreement to acquire a controlling interest and pursue a full merger subject to approvals.

Under the structure referenced in the scheme disclosures, Dabur initially acquired 51% of Sesa’s Cumulative Redeemable Preference Shares (CRPS). The purpose of the broader amalgamation is to complete the integration of Sesa Care into Dabur’s corporate structure through a court-approved arrangement route.

Key dates: appointed date, order date, and what is pending

The scheme’s appointed date is April 1, 2026. This is the date from which the amalgamation is typically accounted for, subject to the scheme’s terms and legal effectiveness. The order date is September 24, 2026, when the NCLT sanctioned the amalgamation.

However, the merger will become effective only upon completion of necessary statutory filings and other conditions under the scheme. This distinction matters for investors tracking when the legal merger takes effect versus when accounting impacts may be reflected, depending on applicable rules and the scheme’s implementation steps.

How the NCLT process played out in 2026

The NCLT had reserved its order on August 24, 2026, following the second motion petition hearing. Dabur informed the exchanges that it received this information on August 24, 2026 at 03:30 p.m. In the same set of disclosures, Dabur said it would issue further notifications and update its website once it received the final copy of the order.

Statutory authorities recorded their no-objection to the sanctioning of the scheme under Sections 230 to 232 of the Companies Act, 2013. The September 24, 2026 order completes this phase by providing the tribunal’s sanction, taking the merger closer to implementation subject to filings.

Earlier approvals: NCLT’s March 12 direction for meetings

Before the final sanction, the NCLT, New Delhi Bench, passed an order on March 12, 2026 approving the proposed scheme for the limited purpose of directing the convening of meetings for Dabur’s stakeholders. The tribunal directed Dabur India to convene meetings of its equity shareholders and unsecured creditors to consider and approve the scheme.

For Dabur India (the transferee company), the order referenced meetings of 4,87,801 equity shareholders and 2,034 unsecured creditors, with quorum requirements of not less than 75% in value for each class. Meetings for Dabur’s single secured creditor and three NCD holders were dispensed with, as they provided 100% in value consent.

For Sesa Care (the transferor company), the order noted that consent was secured from 100% in value of equity and preference shareholders. The transferor company’s unsecured creditors provided 98.94% in value written consent, exceeding the 90% threshold under Section 230(9), leading to dispensation of the meeting requirement. The transferor company was stated to have NIL secured creditors, so that meeting was also dispensed with.

Exchange and regulatory steps: BSE observation letter

Dabur also disclosed receiving an observation letter from BSE in December 2025 with “no adverse observations” on the scheme. This indicated that the exchange had reviewed the proposal and did not flag issues at that stage, allowing Dabur to proceed further in the approval process.

The company also stated the scheme remained subject to various statutory and regulatory approvals, as well as approvals from the shareholders and creditors of the companies involved, as applicable.

Transaction economics: stake purchase and enterprise value snapshot

When Dabur announced the transaction on October 30, 2024, it said it would acquire 51% of the total paid-up CRPS of Sesa from existing shareholder True North at face value for ₹12.59 crore. Dabur’s board later approved the amalgamation of Sesa Care on May 26, 2025.

Disclosures also referenced debt associated with Sesa being backed by Dabur’s corporate guarantee. One disclosure cited debt of ₹289 crore, and another cited debt of ₹299 crore, alongside an estimated enterprise value in the range of ₹315 crore to ₹325 crore.

Snapshot table: the amalgamation at a glance

Timeline table: from announcement to sanction

Market impact: what investors should track now

From a markets perspective, the NCLT sanction reduces regulatory uncertainty around the corporate action. The remaining steps are procedural but important, including filing requirements and fulfillment of scheme conditions before the merger is legally effective.

Investors will likely monitor Dabur’s exchange notifications for confirmation that the final order copy has been received and that filings have been completed. They may also track any disclosures around integration timelines, accounting treatment from the appointed date of April 1, 2026, and how the combined hair care portfolio is positioned within Dabur’s FMCG strategy.

Analysis: why this matters for Dabur’s hair care portfolio

The amalgamation is designed to integrate Sesa Care, positioned as a premium Ayurvedic hair care brand, into Dabur’s existing hair care portfolio. For a consumer company, bringing a subsidiary fully into the listed entity can simplify governance, consolidate cash flows, and streamline decision-making, subject to the scheme’s final effectiveness.

The transaction structure also shows how Dabur approached the deal in phases: first, acquiring a controlling 51% position in CRPS, and then pursuing a full court-approved merger. The NCLT’s sanction aligns with earlier steps such as the BSE observation letter and stakeholder meeting process directed by the tribunal in March 2026.

Conclusion: next formal step is statutory filings

With the NCLT sanction dated September 24, 2026, the Dabur India-Sesa Care amalgamation has crossed a major regulatory checkpoint. The scheme’s appointed date is April 1, 2026, but the merger will take effect only after statutory filings and other conditions are completed.

Dabur has said it will notify stock exchanges and update its website upon receipt of the final order copy, making those filings and related disclosures the next key items on the timeline.